X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
humans (18) 18
animals (12) 12
mice (12) 12
oncology (12) 12
female (11) 11
pharmacokinetics (11) 11
pharmacology & pharmacy (11) 11
male (10) 10
cancer therapies (8) 8
chemotherapy (8) 8
cancer (7) 7
clinical trials (7) 7
in-vitro (6) 6
adult (5) 5
analysis (5) 5
apoptosis (5) 5
drug dosages (5) 5
drug therapy (5) 5
lung cancer (5) 5
medicine (5) 5
plasma (5) 5
research (5) 5
tumors (5) 5
aged (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
antineoplastic agents - pharmacokinetics (4) 4
cell line, tumor (4) 4
health aspects (4) 4
india (4) 4
kinases (4) 4
middle aged (4) 4
paclitaxel (4) 4
patient outcomes (4) 4
patients (4) 4
pemetrexed (4) 4
pharmacology/toxicology (4) 4
radiation therapy (4) 4
studies (4) 4
tissue distribution (4) 4
adolescent (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic agents - pharmacology (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic agents, phytogenic - administration & dosage (3) 3
antioxidants - pharmacology (3) 3
area under curve (3) 3
breast cancer (3) 3
care and treatment (3) 3
cell cycle - drug effects (3) 3
cell proliferation - drug effects (3) 3
cell survival - drug effects (3) 3
child (3) 3
drugs (3) 3
laboratories (3) 3
methods (3) 3
neoplasms - drug therapy (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
paclitaxel - administration & dosage (3) 3
pharmacology (3) 3
proteins (3) 3
risk factors (3) 3
signal transduction - drug effects (3) 3
survival analysis (3) 3
time factors (3) 3
treatment outcome (3) 3
xenograft model antitumor assays (3) 3
young adult (3) 3
administration, oral (2) 2
anti-cancer drugs (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents, phytogenic - pharmacokinetics (2) 2
apoptosis - drug effects (2) 2
binding sites (2) 2
bioavailability (2) 2
biodistribution (2) 2
biomedicine (2) 2
cancer research (2) 2
cell cycle (2) 2
cells (2) 2
chemistry, analytical (2) 2
chemistry, medicinal (2) 2
chemotherapeutic-agents (2) 2
child, preschool (2) 2
chromatography (2) 2
chromatography, high pressure liquid - methods (2) 2
chronic myeloid leukemia (2) 2
comparative pharmacokinetics (2) 2
complications and side effects (2) 2
computer simulation (2) 2
cysteine (2) 2
cytochrome p-450 (2) 2
cytokines (2) 2
cytokines - metabolism (2) 2
cytotoxicity (2) 2
deoxyribonucleic acid--dna (2) 2
design (2) 2
dna damage (2) 2
dosage and administration (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


05/2011
Background: Administering drugs outside the terms of their official labeling is called off-label use. In the West, oncologists often use drugs off-label, which... 
Anti-cancer drugs | survey | off-label
Web Resource
Journal of Labelled Compounds and Radiopharmaceuticals, ISSN 0362-4803, 01/2017, Volume 60, Issue 1, pp. 12 - 19
Trastuzumab that targets the human epidermal growth factor receptor type 2 (HER2) is known to benefit patients with HER2+ metastatic breast cancer. The... 
targeted therapy | cells | SCID mice | HER2 | I‐trastuzumab | 131 | breast cancers | I-trastuzumab | Antimitotic agents | Breast cancer | Antineoplastic agents | Analysis | High performance liquid chromatography
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e17652 - e17652
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2016, Volume 78, Issue 2, pp. 353 - 359
Rituximab (MabThera™, Roche) is a chimeric IgG1 monoclonal antibody targeting the CD20 surface antigen on normal and neoplastic B cells. It revolutionized the... 
MabThera | Population pharmacokinetics | DLBCL | Medicine & Public Health | Reditux | Rituximab | Oncology | Cancer Research | Pharmacology/Toxicology | Biosimilar | CHEMOTHERAPY | PHASE-II TRIAL | ANTI-CD20 MONOCLONAL-ANTIBODY | ONCOLOGY | CHOP | PHARMACOLOGY & PHARMACY | ELDERLY-PATIENTS | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Rituximab - pharmacokinetics | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Male | Young Adult | Time Factors | Biosimilar Pharmaceuticals - pharmacokinetics | Vincristine - administration & dosage | Adult | Female | Vincristine - pharmacokinetics | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Biosimilar Pharmaceuticals - administration & dosage | Enzyme-Linked Immunosorbent Assay | Lymphoma, Large B-Cell, Diffuse - pathology | Antibodies, Monoclonal, Murine-Derived - pharmacokinetics | Kaplan-Meier Estimate | Survival Rate | Doxorubicin - pharmacokinetics | Rituximab - administration & dosage | Prednisone - pharmacokinetics | Aged | Cyclophosphamide - pharmacokinetics | Infusions, Intravenous | Nonlinear Dynamics | Developing countries | Lymphomas | B cells | Analysis | Immunoglobulin G | Resveratrol
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 09/2014, Volume 472, Issue 1-2, pp. 214 - 223
Several molecular inheritances have severely restrained the peroral delivery of taxanes. The main objective of the present investigation was to develop a... 
Cationic nanoparticles | Nanosuspension | Pgp inhibitors | Paclitaxel | Oral delivery | Oral anticancer | PERMEABILITY | DOCETAXEL | BIOAVAILABILITY | P-GLYCOPROTEIN | IN-VITRO | THERAPY | PHARMACOKINETICS | FORMULATIONS | DRUGS | NANOSUSPENSIONS | PHARMACOLOGY & PHARMACY | Hypromellose Derivatives - chemistry | Skin Neoplasms - drug therapy | Nanoparticles - chemistry | Melanoma, Experimental - drug therapy | Ileum - metabolism | Paclitaxel - pharmacokinetics | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Arginine - analogs & derivatives | Gastrointestinal Tract - pathology | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Surface Properties | Clarithromycin - administration & dosage | Drug Compounding | Paclitaxel - blood | Paclitaxel - administration & dosage | Antineoplastic Agents, Phytogenic - pharmacokinetics | Antineoplastic Agents, Phytogenic - blood | Skin Neoplasms - pathology | Cytochrome P-450 CYP3A Inhibitors - administration & dosage | Administration, Oral | Melanoma, Experimental - pathology | Antineoplastic Agents, Phytogenic - chemistry | Rats, Sprague-Dawley | Arginine - chemistry | Particle Size | Animals | Tumor Burden - drug effects | Chickens | Cyclosporine - administration & dosage | Mice | Nanoparticles - administration & dosage | Antimitotic agents | Elite (Social sciences) | Antineoplastic agents | Cytochrome P-450
Journal Article
Indian Journal of Medical Research, ISSN 0971-5916, 02/2016, Volume 143, Issue FEBRUARY, pp. 145 - 159
Journal Article
Indian Journal of Anaesthesia, ISSN 0019-5049, 12/2015, Volume 59, Issue 12, pp. 767 - 768
  A regulatory agency (e.g., Drugs Controller General of India, United States Food and Drug Administration [USFDA]) approves a drug for a particular... 
Off-label prescribing | Medicine | Care and treatment | Safety and security measures | Practice | Forecasts and trends | Patients | Standards | Heart failure | Clinical trials | Prescription drugs | Pharmaceutical industry | Drug dosages
Journal Article
Journal Article
Laryngoscope Investigative Otolaryngology, ISSN 2378-8038, 10/2018, Volume 3, Issue 5, pp. 372 - 376
Education regarding the health effects associated with tobacco use has made important progress worldwide over the last few decades. Still, tobacco remains a... 
DNA adduct | Head and neck cancer | tobacco | nitrosamines | Level of Evidence | carcinogen
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 12/2016, Volume 11, pp. 6435 - 6448
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 3761 - 3761
Abstract Introduction: Dosing of 6-mercaptopurine (6MP) has remained empirical in acute lymphoblastic leukemia (ALL) with leucocyte count and TPMT genotype... 
Journal Article
Journal of Labelled Compounds and Radiopharmaceuticals, ISSN 0362-4803, 01/2017, Volume 60, Issue 1, pp. 12 - 19
Journal Article
NATIONAL MEDICAL JOURNAL OF INDIA, ISSN 0970-258X, 11/2018, Volume 31, Issue 6, pp. 334 - 338
Background. An 'informed consent' is a legal and ethical requirement for research involving human subjects. Studies assessing the validity of informed consent... 
MEDICINE, GENERAL & INTERNAL | IMPACT | Surveys | Clinical trials | Informed consent (Medical law) | Research | Oncology, Experimental | Cancer | Studies | Human subjects | Ethics | Medical research | Quality | Questionnaires | Informed consent | Patients | Cancer therapies
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e18510 - e18510
Journal Article
Current Science (Bangalore), ISSN 0011-3891, 04/2014, Volume 106, Issue 8, pp. 1058 - 1060
Various strategies and models have been developed to implement successful technology transfer in Indian universities, many of which are inspired from existing... 
Journal Article
Current Science, ISSN 0011-3891, 2014, Volume 106, Issue 8, pp. 1058 - 1060
Various strategies and models have been developed to implement successful technology transfer in Indian universities, many of which are inspired from existing... 
MULTIDISCIPLINARY SCIENCES
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.